4//SEC Filing
John Anish M. 4
Accession 0001493152-22-016904
CIK 0001642380other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 7:49 PM ET
Size
5.6 KB
Accession
0001493152-22-016904
Insider Transaction Report
Form 4
John Anish M.
SVP, Finance, and Interim CFO
Transactions
- Award
Option to Purchase Common Stock
2022-06-01+50,000→ 50,000 totalExercise: $0.99Exp: 2022-06-01→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]25% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date.
Documents
Issuer
Oncocyte Corp
CIK 0001642380
Entity typeother
Related Parties
1- filerCIK 0001933248
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 7:49 PM ET
- Size
- 5.6 KB